02 — Research

Programmes & collaborations.

My work sits between clinical dermatology, pharmacoepidemiology and evidence synthesis.

Programmes I lead

MRC Clinician Scientist Fellowship · 2024–2029

MERMAID

Making Effectiveness Research better by meta-analysing Trial and Real World Evidence in Immune-Mediated inflammatory Diseases. A £1.4 m programme funded by the Medical Research Council to develop and apply methods for combining randomised trial data with registry-based observational data, so that patients and clinicians have more useful evidence about which treatment to choose, and when.

Funder →

Global initiative

GUIDEMAP

The Global Guidelines in Dermatology Mapping Project identifies, catalogues and critically appraises clinical practice guidelines across dermatology — psoriasis, atopic eczema, urticaria, alopecia areata and beyond — using an explicit framework for evidence-based dermatology.

GUIDEMAP →

Programmes I contribute to

BAD · Steering committee

BADBIR

The British Association of Dermatologists Biologics and Immunomodulators Register — a UK and Republic of Ireland prospective cohort of patients with moderate-to-severe psoriasis on systemic therapies. Most of my work on drug survival, comparative effectiveness and serious infection has been built on BADBIR.

badbir.org →

BAD · Steering committee

GRASS-UK

The Global Register of Alopecia areata disease Severity and treatment Safety — United Kingdom: a prospective register hosted at the University of Manchester and managed by the BAD, studying the safety and effectiveness of alopecia areata treatments in real-world NHS practice as part of an international collaboration.

GRASS-UK →

BAD · Steering committee

UKKCC

The UK Keratinocyte Cancer Collaborative brings together clinicians, pathologists and scientists to advance keratinocyte cancer research, anchored on a national tissue biobank and an evolving molecular atlas of cutaneous squamous cell carcinoma.

UKKCC →

Living network meta-analysis

Eczema Therapies

A living network meta-analysis of systemic therapies for atopic dermatitis, kept up-to-date with quarterly literature searches and presented through a user-centred website to support shared decision-making between patients and clinicians.

eczematherapies.com →

Editorial roles

Co-Section Editor, Epidemiology section — British Journal of Dermatology (2026–).

Committee & advisory roles

Councillor, International Psoriasis Council (2025–).
Co-Deputy Chair, UK Dermatology Clinical Trials Network (2024–2026).
Member, NICE Technology Appraisal Committee D (2023–2026).
Member, British Association of Dermatologists Research Subcommittee (2023–2026).
Member, Eczema UK Grant Advisory Panel (2025–).
Member, British Skin Foundation Large Grants Advisory Committee (2023–2025).
Steering committee member, European Dermato-Epidemiology Network (EDEN) (2023–).
Steering committee member, BADBIR.
Steering committee member, GRASS-UK.
Steering committee member, UK Keratinocyte Cancer Collaborative (UKKCC), Epidemiology workstream (2020–2026).

Guideline panels

Chair — British Association of Dermatologists guideline for methotrexate.
Member — British Association of Dermatologists guideline for biologic therapy for psoriasis.
Member — British Association of Dermatologists guideline for hidradenitis suppurativa.

Selected awards

2025 — ILDS Young Dermatologist International Achievement Award (Europe), 4th ILDS World Skin Summit, Cape Town.
2025 — touchDERMATOLOGY Future Leader.
2024 — MRC Clinician Scientist Fellowship for MERMAID (£1.4 m).
2024 — CIHR-IMHA Inclusive Research Excellence Prize (Open Science & Team Science).
2023 — BSMD Medical Dermatology Prize for Best Oral Presentation, BAD Annual Meeting.
2019 — British Association of Dermatologists Clive Archer THESIS Fellowship.
2019 — Royal College of Physicians Turner-Warwick Lectureship, North Western Region.
2018 — Royal Society of Medicine Trainee Research Prize, Dermatology section.
2015 — NIHR Doctoral Research Fellowship.